In addition, the miRNA processing- and B-cell differentiation-regulator and Argonaut 2 (AGO2) [21,135,136] was shown to be up-regulated in MM patients with high-risk disease [126]. The gene discussed is AGO2; the disease is Miyoshi myopathy.